Fibroblast (FGFs) and insulin (IGF) growth factor pathways are among 10 most recurrently altered genomic pathways in pancreatic ductal adenocarcinoma (PDAC). The gene discussed is IGF1; the disease is pancreatic ductal adenocarcinoma.